摘要
目的:探讨艾迪注射液对肺癌放疗患者血清细胞因子的影响。方法:将40例肺癌患者,随机分为治疗组(20例)和对照组(20例),两组均予三维适行放疗(3DCRT),治疗组在此基础上加用艾迪注射液。比较放疗前后两组患者血清中白细胞介素-6(IL-6),肿瘤坏死因子-α(TNF-α)和转化生长因-β(TGF-β)水平的变化及放射性肺炎(RP)发生率的差异。结果:治疗组在放疗结束后细胞因子IL-6,TNF-α和TGF-β的水平明显低于对照组,二者比较差异有显著性(P<0.05);两组RP的发生率相近。结论:艾迪注射液能降低肺癌放疗患者血清细胞因子IL-6,TNF-α和TGF-β的水平,延缓放射性肺炎的进展,有效预防放射性肺炎的发生。
Objective:It is to explore the effect of Aidi Injecttion on the expression of radiotherapy for lung cancer patients.Method:Fourty cases of lung cancer were randomly divided into treatment group(20 cases) and control group(20 cases).The two groups were given three-dimensional conformal radiation therapy(3D CRT).Meanwhile,the treatment group was added Aidi injecttio.There were some indices compared before and after radiotherapy including the serum interleukin-6(IL-6),the tumor necrosis factor-α(TNF-α) and the transforming growth factor-β(TGF-β).And then,the incidence of the radiation pneumonia were also compared between two groups.Result:After the end of treatment,the IL-6,the TNF-α and the TGF-β of the treatment group were lower than those of the control group.There was significant difference(P0.05).Nevertheless there were no significat differences between two groups about incidence of the radiation pneumonitis.Conclusion:Aidi injecttion could relieve the progress of Radiation pneumonitis through decreasing levels of the IL-6,the TNF-α and the TGF-β,thus,prevention of the occurrence of radiation pneumonia.
出处
《中国实验方剂学杂志》
CAS
北大核心
2013年第8期323-325,共3页
Chinese Journal of Experimental Traditional Medical Formulae
基金
河北省中医药管理局科研计划项目(2012136)
关键词
艾迪注射液
肺癌
放疗
细胞因子
Aidi injecttion
lung cancer
radiotherapy
cytokine